Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

KEY publications
IPC's Chief Medical Officer has selected the following publications as important to the understanding of the impact of COVID-19 and psoriasis. 

Teledermatologic monitoring for chronic cutaneous autoimmune diseases with smartworking during Covid-19 emergency in a tertiary center in Italy. [published online ahead of print, 2020 May 26]. Brunasso AMG, Massone C.   2020;e13495. doi:10.1111/dth.13695.

 

Chilblain-like lesions: a case series of 41 patients during the COVID-19 pandemicLópez-Robles J, de la Hera I, Pardo J, Martínez J, Cutillas-Marco E. Clin Exp Dermatol. 2020 May 5. doi: 10.1111/ced.14275. [Epub ahead of print]


Performing dermoscopy in the COVID-19 pandemic. Goldust M, Zalaudek I, Gupta A, Lallas A, Rudnicka L, Navarini AA. Dermatol Ther. 2020 May 5:e13506. doi: 10.1111/dth.13506. [Epub ahead of print] 

View all

this weeks' publications on covid-19 & psoriasis

Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy.

J Eur Acad Dermatol Venereol. 2020 Jul 31;:

Authors: Talamonti M, Galluzzo M, Chiricozzi A, Quaglino P, Fabbrocini G, Gisondi P, Marzano AV, Potenza C, Conti A, Parodi A, Belloni Fortina A, Bardazzi F, Argenziano G, Rongioletti F, Stingeni L, Micali G, Loconsole F, Venturini M, Bongiorno MR, Feliciani C, Rubegni P, Amerio P, Fargnoli MC, Pigatto P, Savoia P, Nisticò SP, Giustini S, Carugno A, Cannavò SP, Rech G, Prignano F, Offidani A, Lombardo M, Zalaudek I, Bianchi L, Peris K, PSO-BIO-COVID study group

Abstract
The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, is creating an unprecedented global public health emergency with the continuous growth of infected individuals worldwide. Italy was one of the first European country to face the first wave of infection outside mainland China. The first case of COVID-19 was confirmed in Lombardy on February 20th , 2020, and subsequently, a rapid increase in the number of detected cases was observed, spreading through Italy and the rest of Europe.3 As of April 22nd , confirmed COVID-19 cases in Italy were 183,957.

PMID: 32735716 [PubMed - as supplied by publisher]

VIEW ALL ON PUBMED

resources from our industry partners

 AbbVie
Amgen
Novartis
UCB

We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.
OK